Eppendorf AG-医療機器分野:企業M&A・提携分析

◆英語タイトル:Eppendorf AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010947
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eppendorf AG (Eppendorf) is a life science company. The company develops and produces equipment and services for use in laboratory applications such as liquid handling, cell handling, and sample handling. Its product portfolio includes automated pipetting systems, centrifuges, dispensers, mixers, biological shakers, among others. The company also offers other services such as training, maintenance, application support, technical support, quality and regulatory support, installation and operational qualification, calibration and validation. Eppendorf offers its products to commercial research institutes, academic institutions, chemical and food industries, forensics and other industrial companies. The company operates through its direct offices and subsidiaries in the Americas, Europe, the Middle East, Asia-Pacific and Africa. Eppendorf is headquartered in Hamburg, Germany.

Eppendorf AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eppendorf AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Eppendorf AG, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Eppendorf AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Eppendorf AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Eppendorf AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Eppendorf AG, Medical Equipment, Deal Details 10
Partnerships 10
Vela Diagnostics Enters Into Co-Development Agreement With Eppendorf 10
Eppendorf Enters Into Distribution Agreement With AITBIOTECH 11
Eppendorf Enters into Licensing Agreement with Life Tech and Alpha Labs 12
Eppendorf Enters into Licensing Agreement with SensoQuest 13
Eppendorf Enters Into Licensing Agreement With Peqlab Biotechnologie 14
Eppendorf Enters Into Licensing Agreement With Agilent Technologies 15
Eppendorf Enters Into Licensing Agreement With Bibby Scientific 16
Eppendorf Enters Into Licensing Agreement With Analytik Jena 17
Eppendorf Enters Into Licensing Agreement With Takara Bio 18
Eppendorf Enters Into Licensing Agreement With Bulldog Bio 19
Eppendorf Enters Into Licensing Agreement With F. Hoffmann-La Roche 20
Asset Transactions 21
Gentel Acquires SilverQuant Technology From Eppendorf 21
Acquisition 22
Eppendorf Acquires Dasgip Group, Developer Of Bioreactor Systems 22
Eppendorf AG – Key Competitors 23
Eppendorf AG – Key Employees 24
Eppendorf AG – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 27
Strategy And Business Planning 27
Mar 02, 2016: Eppendorf India Opens New Facility in Chennai 27
Financial Announcements 28
Apr 28, 2016: Eppendorf continues successful development 28
Corporate Communications 29
Jan 13, 2017: Eppendorf: William Linton is new member of the Supervisory Board 29
Oct 31, 2016: Changes in the Management Board of Eppendorf 30
Jun 06, 2016: Philipp von Loeper to be new Chairman of the Supervisory Board of Eppendorf 31
Product News 32
May 30, 2016: Eppendorf Expands Single-Use Vessel Portfolio for Microbial Fermentation 32
May 02, 2016: Advanced pipetting with Eppendorf’s new Multipettes/Repeaters takes the strain out of serial dispensing 33
May 02, 2016: Eppendorf Centrifuge 5920 R: The New Benchmark in Capacity and Performance 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Eppendorf AG, Medical Equipment, Key Facts, 2016 2
Eppendorf AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Eppendorf AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Eppendorf AG, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Eppendorf AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Eppendorf AG, Deals By Market, 2011 to YTD 2017 8
Eppendorf AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Vela Diagnostics Enters Into Co-Development Agreement With Eppendorf 10
Eppendorf Enters Into Distribution Agreement With AITBIOTECH 11
Eppendorf Enters into Licensing Agreement with Life Tech and Alpha Labs 12
Eppendorf Enters into Licensing Agreement with SensoQuest 13
Eppendorf Enters Into Licensing Agreement With Peqlab Biotechnologie 14
Eppendorf Enters Into Licensing Agreement With Agilent Technologies 15
Eppendorf Enters Into Licensing Agreement With Bibby Scientific 16
Eppendorf Enters Into Licensing Agreement With Analytik Jena 17
Eppendorf Enters Into Licensing Agreement With Takara Bio 18
Eppendorf Enters Into Licensing Agreement With Bulldog Bio 19
Eppendorf Enters Into Licensing Agreement With F. Hoffmann-La Roche 20
Gentel Acquires SilverQuant Technology From Eppendorf 21
Eppendorf Acquires Dasgip Group, Developer Of Bioreactor Systems 22
Eppendorf AG, Key Competitors 23
Eppendorf AG, Key Employees 24
Eppendorf AG, Subsidiaries 25

★海外企業調査レポート[Eppendorf AG-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anaren, Inc.:企業の戦略・SWOT・財務情報
    Anaren, Inc. - Strategy, SWOT and Corporate Finance Report Summary Anaren, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Warren Resources Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Warren Resources Inc (Warren Resources) is an oil and gas company that acquires, explores and develops crude oil and natural gas in the US. The company priovides exploration and development of waterflood oil recovery properties in the Wilmington Field in the Los Angeles Basin of California. …
  • InnoPharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary InnoPharma Inc (InnoPharma), a subsidiary of Pfizer Inc is a healthcare products provider that develops generic and pharmaceutical products. The company develops formulations, which include solutions, suspensions, lyophilized, emulsions, liposomes, lipid complexes, polypeptides and carbohydr …
  • Shunfeng International Clean Energy Ltd (1165):電力:M&Aディール及び事業提携情報
    Summary Shunfeng International Clean Energy Ltd (Shunfeng International), formerly Shunfeng Photovoltaic International Ltd is a renewable energy company that manufactures and markets solar photovoltaic products. The company’s products include monocrystalline silicon solar cells, polycrystalline sili …
  • Oasmia Pharmaceutical AB (OASM):製薬・医療:M&Aディール及び事業提携情報
    Summary Oasmia Pharmaceutical AB (Oasmia Pharmaceutical) is a pharmaceutical company that develops drugs for human and veterinary oncology. The company’s product portfolio consists of animal health products that include doxophos vet and paccal vet and human health products which include doxophos, pa …
  • Wacker Neuson Se:企業の戦略・SWOT・財務分析
    Wacker Neuson Se - Strategy, SWOT and Corporate Finance Report Summary Wacker Neuson Se - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Mizuno Corporation (8022):企業の財務・戦略的SWOT分析
    Mizuno Corporation (8022) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • MAN SE:企業の戦略・SWOT・財務分析
    MAN SE - Strategy, SWOT and Corporate Finance Report Summary MAN SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Miromatrix Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Miromatrix Medical Inc (Miromatrix Medical) is a life science company that develops regenerative medicines. The company offers MIRODERM biologic wound matrix, MIROMESH biologic matrix, liver function restoration, kidney products, diabetes treatment and cortical strut. It creates biological r …
  • TPI Composites Inc (TPIC):企業の財務・戦略的SWOT分析
    TPI Composites Inc (TPIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Distilleries Company of Sri Lanka PLC:戦略・SWOT・企業財務分析
    Distilleries Company of Sri Lanka PLC - Strategy, SWOT and Corporate Finance Report Summary Distilleries Company of Sri Lanka PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • China Railway Construction Corporation Ltd:戦略・SWOT・企業財務分析
    China Railway Construction Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary China Railway Construction Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • CryoLife Inc (CRY)-医療機器分野:企業M&A・提携分析
    Summary CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company’s portfolio encompasses preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide …
  • AutoNation, Inc.:企業の戦略・SWOT・財務情報
    AutoNation, Inc. - Strategy, SWOT and Corporate Finance Report Summary AutoNation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Commonwealth Bank of Australia:企業のM&A・事業提携・投資動向
    Commonwealth Bank of Australia - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Commonwealth Bank of Australia Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Pulse Seismic Inc (PSD):企業の財務・戦略的SWOT分析
    Summary Pulse Seismic Inc (Pulse), formerly Pulse Data Inc is a provider of seismic data library for oil and gas exploration. The company acquires, markets and licenses 2D and 3D seismic data to the western Canadian energy sector. It offers services such as project cost tracking, scouting, geophysic …
  • Eureka Forbes Limited:企業の戦略的SWOT分析
    Eureka Forbes Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • China Life Insurance Co Ltd:戦略・SWOT・企業財務分析
    China Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Senzime AB (SEZI)-製薬・医療分野:企業M&A・提携分析
    Summary Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company's product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients …
  • Straumann Holding AG (STMN)-医療機器分野:企業M&A・提携分析
    Summary Straumann Holding AG (Straumann) develops dental implants and devices. Straumann’s product portfolio includes dental implants, active surfaces, prosthetic components, digital solutions such as intra-oral scanning, and CADCAM, bone substitutes, and regenerative membranes. The company categori …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆